Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma (Q33504540)

27 July 2017

title

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma (English)

1 reference

27 July 2017

Tulpule A

1

1 reference

27 July 2017

Schiller G

2

1 reference

27 July 2017

Harvey-Buchanan LA

3

1 reference

27 July 2017

Lee M

4

1 reference

27 July 2017

Espina BM

5

1 reference

27 July 2017

Khan AU

6

1 reference

27 July 2017

Boswell W

7

1 reference

27 July 2017

Nathwani B

8

1 reference

27 July 2017

Levine AM

9

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

83

1 reference

27 July 2017

issue

11

1 reference

27 July 2017

page(s)

2370-2376

1 reference

Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Cladribine (2-chlorodeoxyadenosine)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819981201%2983%3A11%3C2370%3A%3AAID-CNCR17%3E3.0.CO%3B2-M

10.1002/(SICI)1097-0142(19981201)83:11<2370::AID-CNCR17>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

release_tczgl57s4rgjvmfau7xqdwftsi

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tczgl57s4rgjvmfau7xqdwftsi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference